Norman Fields Gottscho Capital Management’s Novartis NVS Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,877	Closed	-$1.48M	–	79
2016 Q3	$1.48M	Buy	20,877 +2,957	+17%	+$215K	0.98%	24
2016 Q2	$1.32M	Buy	17,920 +8,507	+90%	+$588K	0.93%	26
2016 Q1	$611K	Buy	+9,413	New	+$640K	0.41%	44

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Norman Fields Gottscho Capital Management's NVS Position: Q4 2016 in Review

Norman Fields Gottscho Capital Management sold out of Novartis (NVS) in Q4 2016, closing a stake of 20,877 shares — an estimated $1.48M sold.

Norman Fields Gottscho Capital Management first reported a position in NVS in Q1 2016 and held it in 3 quarters. The position peaked at $1.48M in Q3 2016. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Norman Fields Gottscho Capital Management reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Norman Fields Gottscho Capital Management sold 20,877 Novartis shares in Q4 2016, an estimated $1.48M.
Norman Fields Gottscho Capital Management first reported a position in Novartis in Q1 2016 and held it in 3 quarters.
Norman Fields Gottscho Capital Management's Novartis position peaked at $1.48M in Q3 2016.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q4 2016, filed 4 Jan 2017.